NCT00926081

Brief Summary

The aim of the investigators' study is to analyze the value of supervised exercise training combined with medical therapy versus best medical treatment only with respect to quality of life. Furthermore, the investigators aim to evaluate the effect of supervised exercise training on microcirculation, peripheral endothelial progenitor cells as well as on future major cardiovascular adverse events.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2007

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2007

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

June 22, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 23, 2009

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2013

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
Last Updated

January 4, 2012

Status Verified

December 1, 2011

Enrollment Period

6.1 years

First QC Date

June 22, 2009

Last Update Submit

December 30, 2011

Conditions

Keywords

Peripheral Artery DiseaseQuality of LifeOutcomeEndothelial Progenitor CellsMicrocirculation

Outcome Measures

Primary Outcomes (1)

  • Quality of Life

    1 year

Secondary Outcomes (5)

  • Endothelial progenitor cells

    1 year

  • Inflammatory parameters

    1 year

  • Ankle brachial index

    1 year

  • Pain-free walking distance

    1 year

  • Peripheral transcutaneous oxygen pressure

    1 year

Study Arms (2)

Best medical treatment

NO INTERVENTION

Patients with peripheral artery disease receiving best medical treatment only

Supervised exercise training

ACTIVE COMPARATOR

Patients with peripheral artery disease receiving best medical treatment plus supervised exercise training

Behavioral: Supervised exercise training

Interventions

A standardized supervised exercise training program

Also known as: Standardized supervised exercise training
Supervised exercise training

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Peripheral artery disease with intermittent claudication (Rutherford 2-3)
  • Exercise tolerance
  • Ankle brachial index \< 0,9
  • Ability to life independently at home

You may not qualify if:

  • No PAD
  • Asymptomatic PAD
  • Ischemic rest pain
  • Exercise tolerance limited by other factors than claudication (e.g., coronary artery disease, dyspnoea, poorly controlled blood pressure, any kind of restriction of the musculoskeletal system which might have an influence on the efficiency of exercise training)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Angiology, Vienna Medical University

Vienna, Vienna, A-1090, Austria

RECRUITING

Related Publications (1)

  • Schlager O, Hammer A, Giurgea A, Schuhfried O, Fialka-Moser V, Gschwandtner M, Koppensteiner R, Steiner S. Impact of exercise training on inflammation and platelet activation in patients with intermittent claudication. Swiss Med Wkly. 2012 Aug 14;142:w13623. doi: 10.4414/smw.2012.13623. eCollection 2012.

MeSH Terms

Conditions

Peripheral Arterial Disease

Condition Hierarchy (Ancestors)

AtherosclerosisArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular DiseasesPeripheral Vascular Diseases

Study Officials

  • Sabine Steiner-Boeker, MD

    Department of Angiology, Medical University Vienna

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr.

Study Record Dates

First Submitted

June 22, 2009

First Posted

June 23, 2009

Study Start

November 1, 2007

Primary Completion

December 1, 2013

Study Completion

December 1, 2014

Last Updated

January 4, 2012

Record last verified: 2011-12

Locations